Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vyant Bio (VYNT)
OTHER OTC:VYNT
Holding VYNT?
Track your performance easily
VYNT Stock Chart & Stats
Day’s Range$0.18 - $0.2
52-Week Range― - ―
Previous Close$0.19
Volume19.12K
Average Volume (3M)N/A
Market Cap
$1.23M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Vyant Bio News
PremiumPress Releases
Vyant Bio Provides Update on Winddown Activities
PremiumPress Releases
Vyant Bio Provides Update on Winddown Activities
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
2.00% Other Institutional Investors
98.00% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
VYNT FAQ
What was Vyant Bio’s price range in the past 12 months?
Currently, no data Available
What is Vyant Bio’s market cap?
Currently, no data Available
When is Vyant Bio’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Vyant Bio’s earnings last quarter?
Currently, no data Available
Is Vyant Bio overvalued?
According to Wall Street analysts Vyant Bio’s price is currently Overvalued.
Does Vyant Bio pay dividends?
Vyant Bio does not currently pay dividends.
What is Vyant Bio’s EPS estimate?
Vyant Bio’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vyant Bio have?
Currently, no data Available
What happened to Vyant Bio’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Vyant Bio?
Currently, no hedge funds are holding shares in VYNT
---
Vyant Bio Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Vyant Bio
Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomarker solutions, bio repository solutions, consulting, cytogenetic testing, nucleic acid extraction and purification, flow cytometry, Focus::NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ.
---
VYNT Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Voyager Therapeutics
―
Clearside Biomedical
―
Aptose Biosciences
―
Fennec Pharmaceuticals
―
---